Andrew Barraclough is vice president, design, at GlaxoSmithKline (GSK). With 30 years’ experience at the heart of design and innovation in the healthcare and FMCG sectors spanning Design Business Association, Novartis Consumer Health, Reckitt Benckiser, and Pure Realisation, which he founded, Barraclough joined GlaxoSmithKline in 2011. As vice president of design and innovation, he has continued to push the boundaries of perception of design across 146+ markets for 25+ global brands, including Panadol, Sensodyne, Theraflu, and Flonase. Barraclough’s mission at GSK is to embed world class design thinking and culture across all customer touchpoints.